Genetic/Familial High-Risk Assessment: Breast and OvarianMary B. Daly, Jeffrey N. Weitzel, Jennifer K. Litton et al.|Journal of the National Comprehensive Cancer Network|2010Cited by 650
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian CancerTimothy R. Rebbeck, Saundra S. Buys, Nandita Mitra et al.|JAMA|2015Cited by 507
Proliferative Defect and Embryonic Lethality in Mice Homozygous for a Deletion in the p110α Subunit of Phosphoinositide 3-KinaseLei Bi, Robert L. Nussbaum|Journal of Biological Chemistry|1999Cited by 444
Dent Disease with Mutations in OCRL1R R Hoopes, Steven J. Scheinman, Antony E. Shrimpton et al.|The American Journal of Human Genetics|2005Cited by 332
Germline Mutation in <i>BRCA1</i> or <i>BRCA2</i> and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian CancerFrancisco José Cândido dos Reis, Honglin Song, Ellen L. Goode et al.|Clinical Cancer Research|2014Cited by 160